PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure
A phase 2 trial of Methoxsalen in Skin cancer and Melanoma, run by Therakos LLC, not yet recruiting.
Overview
PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure is a phase 2 interventional study registered as NCT07619898 by Therakos LLC, with 112 participants planned, started 2026-07 and due to reach its primary completion in 2028-12. Interventions recorded: methoxsalen, Extracorporeal photopheresis (ECP), Vedolizumab, Infliximab, Mycophenolate Mofetil (MMF), Azathioprine. Conditions recorded: Colitis, Hepatitis, Melanoma (Skin Cancer).
Linked to the drug Methoxsalen because the registry names it among its interventions and Skin cancer and Melanoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPUVA Maintenance Therapy in Mycosis Fungoides
Shares Methoxsalen (extracorporeal photopheresis) and the tag pipeline.
- TrialExtracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Shares Methoxsalen (extracorporeal photopheresis) and the tag pipeline.
- TrialEarly Phase Study of KESONOTIDE™in Participants With Solid Tumours
Shares Skin cancer (all types) and the tag pipeline.
- TrialIntratumoral N17350 in Advanced Solid Tumors
Shares Melanoma and the tag pipeline.
- TrialPhase II Trial of Ontak With Metastatic Melanoma
Shares Melanoma and the tag pipeline.
- TrialPhase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors
Shares Melanoma and the tag pipeline.
- TrialSafety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Shares Melanoma and the tag pipeline.
- TrialSafety and Efficacy of OBX-115 in Advanced Solid Tumors
Shares Melanoma and the tag pipeline.